Sea Moss (Irish Moss)
Chondrus crispus
A trendy red seaweed sold as a cure-all, but the sweeping wellness claims have essentially no human evidence — and it carries real iodine and heavy-metal risks.
Evidence tier
No Evidence
Research weight
Not supported
Citations
16 verified / 16
Classification
Debunked
⊘
What the evidence says. No credible human evidence supports the marketed claims — widely considered ineffective.
⊘
No credible evidence. The claims below are what marketers assert — not what science supports. This entry is included so you can recognise it.
What is Sea Moss (Irish Moss)?
Sea Moss (Irish Moss) (Chondrus crispus) is a debunked supplement marketed for no claimed benefit (immunity, thyroid support, gut health, weight loss, skin, libido) is supported by direct human trials on chondrus crispus — these are extrapolations from nutrient content or lab/animal data. NutriDex grades the human evidence as No Evidence. Sea moss (Chondrus crispus), also called Irish moss, is a red seaweed that became a billion-dollar social-media "superfood" marketed for immunity, thyroid health, gut health, energy, skin, and weight loss. Despite these sweeping claims, a 2024 review found that human clinical data on Chondrus are essentially absent — almost all reported activity comes from in vitro and animal studies, with marketed benefits inferred from its nutrient profile rather than demonstrated in people. The one robust human trial in this space tested a purified iota-carrageenan nasal spray, not edible sea moss, and cannot be used to justify consuming the seaweed. Meanwhile, sea moss carries documented risks: seaweed is the single largest dietary contributor to iodine, and its iodine content is extremely variable and frequently high enough to push intake well past the tolerable upper limit, causing thyroid dysfunction. It is also a bioaccumulator of arsenic, cadmium, lead, and mercury, so contamination is a genuine safety concern. On balance, the evidence tier for its marketed health claims is "none."
Marketed Claims (unproven)
✕No claimed benefit (immunity, thyroid support, gut health, weight loss, skin, libido) is supported by direct human trials on Chondrus crispus — these are extrapolations from nutrient content or lab/animal data
✕Provides minerals (iodine, calcium, magnesium, potassium, zinc) and prebiotic-type polysaccharide fiber, though no whole-food human outcome trial shows this translates into a health benefit beyond ordinary diet
✕An isolated, purified relative — iota-carrageenan nasal spray (not sea moss itself) — reduced COVID-19 incidence in one RCT, but this does not validate ingesting sea moss gel or capsules
Dosing & Compounds
Use & Legality
No evidence-based therapeutic dose exists. Culinary/supplement use is typically 4-8 g dried (about 1-2 tablespoons of gel) per day, but even this can exceed the 1,100 mcg/day tolerable upper iodine limit because iodine content is unpredictable. There is no established safe or effective standardized dose.
Active Compounds
Safety & Cautions
High-risk product despite its "natural superfood" image. The dominant hazard is iodine excess: sea moss iodine content is highly variable and often very high, so routine use can exceed the 1,100 mcg/day tolerable upper limit and trigger hyper- or hypothyroidism (Wolff-Chaikoff effect), worsen Hashimoto's or Graves' disease, or precipitate new thyroid dysfunction even in people with no prior thyroid problem. As a bioaccumulator, sea moss can concentrate arsenic (including inorganic arsenic), cadmium, lead, and mercury, with cumulative risk to kidneys, nervous system, and cardiovascular health; only buy products with a published certificate of analysis for heavy metals. AVOID or use only under medical supervision if you: have any thyroid disorder, are pregnant or breastfeeding (fetuses/neonates are especially vulnerable to iodine-induced hypothyroidism), have kidney disease, or take thyroid medication (levothyroxine, antithyroid drugs) or blood thinners. Carrageenan content may cause GI upset in some people. Sea moss has not been reviewed by the FDA for safety or efficacy, and product potency/contamination are unregulated. Educational only — always check with your doctor or pharmacist before combining Sea Moss (Irish Moss) with any medicine.
Evidence & Risk Findings ★ 16 studies
Meta-analysis
Candido 2022 (iodine excess in pregnancy meta-analysis)
✓ PubMed
Systematic review and meta-analysis of 10,736 pregnant women: pooled prevalence of excessive iodine intake was 52%, associated with maternal hypothyroxinemia, hypothyroidism and hyperthyroidism, plus neonatal macrosomia and thyroid dysfunction - underscoring the risk of high/variable iodine sources such as sea moss in pregnancy.
Meta-analysis
Katagiri 2017 (excess iodine systematic review/meta-analysis)
✓ PubMed
Systematic review and meta-analysis (50 studies): chronic excess iodine intake was associated with markedly higher odds of overt hypothyroidism (OR 2.78, 95% CI 1.47-5.27) and subclinical hypothyroidism (OR 2.03, 95% CI 1.58-2.62) in adults - directly relevant to iodine-rich sea moss.
Randomized controlled trial
RCT, n=20 (BMC Medicine)
✓ PubMed
In a 2024 randomized double-blind crossover trial, 250 mg twice-daily oral carrageenan (the principal polysaccharide of Chondrus crispus/sea moss) for 2 weeks did not change whole-body insulin sensitivity overall but increased intestinal permeability, and in overweight participants significantly lowered whole-body and hepatic insulin sensitivity and raised CRP and IL-6, indicating carrageenan may promote insulin resistance and subclinical inflammation in higher-BMI individuals.
guideline
ATA position statement
✓ Source
The American Thyroid Association warns that kelp/seaweed and iodine supplements can contain iodine up to several thousand times the daily tolerable upper limit and advises against ingesting more than 500 mcg iodine/day from such supplements for children, adults, and during pregnancy/lactation, noting no thyroid benefit from doses exceeding the 150 mcg RDA.
agency
DoD OPSS safety statement
✓ Source
The U.S. Department of Defense Operation Supplement Safety (OPSS) program states there is insufficient reliable human evidence that sea moss supplements are safe or effective, and flags that their variable iodine content (excess >1 mg/day risking thyroid dysfunction) and potential heavy-metal contamination (arsenic, mercury, lead) make them risky, especially for pregnant, breastfeeding, or thyroid-affected individuals.
RCT
Bhattacharyya 2017 (no-carrageenan diet UC RCT)
✓ PubMed
Randomized double-blind placebo-controlled multicenter trial in ulcerative colitis patients in remission: 3/12 given carrageenan capsules relapsed vs 0 on placebo (P=0.046), with rises in IL-6 (P=0.02) and fecal calprotectin; carrageenan exposure shortened time to relapse. Small but a cautionary signal for IBD.
rct
RCT, n=394 (CARR-COV-02)
✓ Full text
In a multicenter double-blind placebo-controlled trial of 394 healthcare workers, a nasal spray containing iota-carrageenan (a red-seaweed polysaccharide) reduced COVID-19 incidence from 5.0% (placebo) to 1.0% over 21 days, a ~79.8% relative risk reduction — evidence for topical carrageenan against respiratory viruses, not for ingested sea moss.
RCT
Panlasigui 2003 (carrageenan crossover RCT)
✓ PubMed
In a randomized crossover trial in 20 volunteers, an 8-week diet incorporating carrageenan (the dominant polysaccharide of Chondrus crispus/Irish moss) significantly lowered serum total cholesterol (5.44 to 3.64 mmol/L, P<0.0014) and triglycerides (1.28 to 0.87 mmol/L, P<0.0006) and raised HDL-cholesterol (1.25 to 1.65 mmol/L, P<0.0071); LDL unchanged.
Review
Narrative review
✓ Full text
A 2024 review of the genus Chondrus concluded that human clinical data are limited to inadequate, with nearly all reported biological activities resting on in vitro and animal studies and a few single-study claims — meaning sea moss's marketed health benefits are largely unvalidated in people.
review
Narrative review (Nutrients 2024)
✓ PubMed
A 2024 review concluded that carrageenan — the principal polysaccharide of Chondrus crispus (sea moss) — degrades the colonic mucus barrier, alters microbiota (notably reducing Akkermansia muciniphila), and activates TLR4/NF-kB pro-inflammatory signaling in animal and cell models, posing the greatest concern for people with Crohn's disease or ulcerative colitis.
Observational study
n=44 (19 thyroid)
✓ PubMed
A 2020 study of regular seaweed consumers in Norway found a median urinary iodine concentration of ~1,200 mcg/L (well into excessive range) with seaweed as the major contributor, leading the authors to warn consumers about the risk of including macroalgae in the diet.
Clinical study
n=49 consumers
✓ PubMed
In a 2026 non-randomized pre-post study, habitual seaweed consumers had a median iodine intake of ~658 mcg/day (up to 1,516), and after 6 weeks of cessation intake fell to ~189 mcg/day with a significant drop in serum TSH — most marked in the highest-intake consumers, indicating seaweed-driven iodine excess perturbs thyroid signaling.
Risk assessment
9,715 results / 22 countries
✓ Full text
The 2023 EFSA assessment of seaweed and halophyte consumption found that some products (e.g., kombu) can deliver iodine far exceeding the 600 mcg/day tolerable upper level and that seaweed contributes meaningfully to inorganic arsenic, lead, cadmium, and mercury exposure.
Risk assessment
French diet exposure model
✓ PubMed
A 2023 dietary exposure and risk assessment found seaweeds were the strongest dietary contributor to iodine (up to ~33% of intake) while also adding measurable inorganic arsenic, cadmium, lead, and mercury, prompting proposed maximum contaminant limits for seaweed products.
Case report
Case report (term infant)
✓ Full text
A 2021 case report documents transient congenital hypothyroidism in a term infant caused by excessive maternal iodine from daily seaweed intake (wakame miso soup plus weekly hijiki/arame/nori and chlorella) during pregnancy and lactation; because the fetal protective Wolff-Chaikoff effect is immature before week 36, a single bowl of seaweed soup (~500-1,700 mcg iodine) can overload the neonatal thyroid, with TSH remaining >10 mU/L though neurodevelopment was normal at 9 months.
Authoritative body (NIH ODS)
NIH ODS fact sheet
✓ Source
The NIH Office of Dietary Supplements Iodine fact sheet sets the adult tolerable upper intake level at 1,100 mcg/day and notes that whole/sheet seaweed iodine content ranges enormously (about 16 to 2,984 mcg per gram), so seaweed products like sea moss can unpredictably push intake past the UL and that FDA does not require iodine to be listed on labels of naturally iodine-rich foods such as seaweed.